These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 27421245

  • 61. Hepatitis B virus X protein mutant HBxΔ127 promotes proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRT.
    Liu F, You X, Chi X, Wang T, Ye L, Niu J, Zhang X.
    Biochem Biophys Res Commun; 2014 Feb 07; 444(2):128-34. PubMed ID: 24434140
    [Abstract] [Full Text] [Related]

  • 62. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma.
    Bai PS, Xia N, Sun H, Kong Y.
    J Cell Mol Med; 2017 Nov 07; 21(11):3023-3043. PubMed ID: 28557334
    [Abstract] [Full Text] [Related]

  • 63. [The expression of hepatitis B virus X protein and cyclooxygenase-2 in hepatitis B virus-related hepatocellular carcinoma: correlation with microangiogenesis and metastasis, and what is the possible mechanism].
    Liu KG, Shao XL, Xie HH, Xu L, Zhao H, Guo ZH, Li L, Liu J.
    Zhonghua Gan Zang Bing Za Zhi; 2010 Nov 07; 18(11):831-6. PubMed ID: 21138631
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
    Li J, Dai X, Zhang H, Zhang W, Sun S, Gao T, Kou Z, Yu H, Guo Y, Du L, Jiang S, Zhang J, Zhou Y.
    Oncotarget; 2015 Oct 06; 6(30):29196-208. PubMed ID: 26470691
    [Abstract] [Full Text] [Related]

  • 68. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
    Wu YH, Ai X, Liu FY, Liang HF, Zhang BX, Chen XP.
    Mol Med Rep; 2016 Feb 06; 13(2):1345-52. PubMed ID: 26648552
    [Abstract] [Full Text] [Related]

  • 69. C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism.
    Zhang Y, Yan Q, Gong L, Xu H, Liu B, Fang X, Yu D, Li L, Wei T, Wang Y, Wong CN, Lyu Z, Tang Y, Sham PC, Guan XY.
    Oncogene; 2021 Feb 06; 40(6):1147-1161. PubMed ID: 33323975
    [Abstract] [Full Text] [Related]

  • 70. HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3.
    Chen JY, Chen YJ, Yen CJ, Chen WS, Huang WC.
    Oncotarget; 2016 Jan 05; 7(1):473-89. PubMed ID: 26595522
    [Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Hepatitis B virus X protein activates Notch signaling by its effects on Notch1 and Notch4 in human hepatocellular carcinoma.
    Gao J, Xiong Y, Wang Y, Wang Y, Zheng G, Xu H.
    Int J Oncol; 2016 Jan 05; 48(1):329-37. PubMed ID: 26530164
    [Abstract] [Full Text] [Related]

  • 75. Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway.
    Qin X, Li C, Guo T, Chen J, Wang HT, Wang YT, Xiao YS, Li J, Liu P, Liu ZS, Liu QY.
    J Exp Clin Cancer Res; 2017 Oct 19; 36(1):148. PubMed ID: 29052520
    [Abstract] [Full Text] [Related]

  • 76. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.
    Lamontagne J, Steel LF, Bouchard MJ.
    World J Gastroenterol; 2015 Jun 28; 21(24):7375-99. PubMed ID: 26139985
    [Abstract] [Full Text] [Related]

  • 77. Hepatitis B virus suppresses the secretion of insulin-like growth factor binding protein 1 to facilitate anti-apoptotic IGF-1 effects in HepG2 cells.
    Nielsen KO, Mirza AH, Kaur S, Jacobsen KS, Winther TN, Glebe D, Pociot F, Hogh B, Størling J.
    Exp Cell Res; 2018 Sep 15; 370(2):399-408. PubMed ID: 29981339
    [Abstract] [Full Text] [Related]

  • 78. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
    Pang R, Lee TK, Poon RT, Fan ST, Wong KB, Kwong YL, Tse E.
    Gastroenterology; 2007 Mar 15; 132(3):1088-103. PubMed ID: 17383430
    [Abstract] [Full Text] [Related]

  • 79. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.
    Wang Y, Cai J, Zeng X, Chen Y, Yan W, Ouyang Y, Xiao D, Zeng Z, Huang L, Liu A.
    BMC Cancer; 2015 Oct 30; 15():821. PubMed ID: 26514586
    [Abstract] [Full Text] [Related]

  • 80. miR-3928v is induced by HBx via NF-κB/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3.
    Zhang Q, Song G, Yao L, Liu Y, Liu M, Li S, Tang H.
    J Exp Clin Cancer Res; 2018 Jan 29; 37(1):14. PubMed ID: 29378599
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.